1-7 of 7
Emily Barron-Casella
Close
Sort by
Journal Articles

Proteomic Discovery: Elevated Neurogranin Levels in Children with Sickle Cell Disease

Eboni I. Lance, MD, Lisa Faulcon, MD, Zongming Fu, PhD, Jun Yang, PhD, Donna Whyte, MD, John J. Strouse, MD, PhD, Emily Barron-Casella, PhD, Kimberly Jones, Jennifer Van Eck, PhD, James F. Casella, MD, Allen Everett, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2296.
https://doi.org/10.1182/blood-2019-122015
Published: 2019
Journal Articles

Genome-wide association study to identify variants associated with acute severe vaso-occlusive pain in sickle cell anemia

Shruti Chaturvedi, Pallav Bhatnagar, Christopher J. Bean, Martin H. Steinberg, Jaqueline N. Milton, James F. Casella, Emily Barron-Casella, Dan E. Arking, Michael R. DeBaun
Journal: Blood
Blood (2017) 130 (5): 686–688.
https://doi.org/10.1182/blood-2017-02-769661
Published: 2017
Includes: Supplemental data
Journal Articles

Meta-analysis of 2040 sickle cell anemia patients: BCL11A and HBS1L-MYB are the major modifiers of HbF in African Americans

Harold T. Bae, Clinton T. Baldwin, Paola Sebastiani, Marilyn J. Telen, Allison Ashley-Koch, Melanie Garrett, W. Craig Hooper, Christopher J. Bean, Michael R. DeBaun, Dan E. Arking, Pallav Bhatnagar, James F. Casella, Jeffrey Renn Keefer, Emily Barron-Casella, Victor Gordeuk, Gregory J. Kato, Caterina Minniti, James Taylor, Andrew Campbell, Lori Luchtman-Jones, Carolyn Hoppe, Mark T. Gladwin, Yingze Zhang, Martin H. Steinberg
Journal: Blood
Blood (2012) 120 (9): 1961–1962.
https://doi.org/10.1182/blood-2012-06-432849
Published: 2012
Journal Articles

Identification of Thrombospondin-1 and L-Selectin as Potential Plasma Biomarkers of Silent Cerebral Infarct In Children with Sickle Cell Disease Using a Proteomic-Based Approach

Lisa M. Williams, MD, Zongming Fu, PhD, Pratima Dulloor, Kun Yan, PhD, John J. Strouse, MD, PhD, William Savage, MD, Emily Barron-Casella, PhD, Michael R. DeBaun, MD, MPH, Jennifer E. Van Eyk, PhD, Allen Everett, MD, James F. Casella, MD
Journal: Blood
Blood (2010) 116 (21): 259.
https://doi.org/10.1182/blood.V116.21.259.259
Published: 2010
Journal Articles

Genome-Wide Association for Silent Cerebral Infarction (SCI) in Sickle Cell Disease: The Silent Infarct Transfusion Trial (SIT) Cohort.

Pallav Bhatnagar, PhD, Emily Barron Casella, Dan E Arking, PhD, James F. Casella, MD
Journal: Blood
Blood (2009) 114 (22): 2563.
https://doi.org/10.1182/blood.V114.22.2563.2563
Published: 2009
Journal Articles

Proteomic-Based Approach for Biomarker Discovery to Predict Silent Cerebral Infarct in Patients with Sickle Cell Disease.

Lisa M. Williams, MD, Zongming Fu, PhD, Pratima Dulloor, William J Savage, MD, Emily Barron-Casella, PhD, John J. Strouse, MD, PhD, Michael R. DeBaun, MD, MPH, Jennifer Van Eyk, PhD, Allen Everett, MD, James F. Casella, MD
Journal: Blood
Blood (2009) 114 (22): 2579.
https://doi.org/10.1182/blood.V114.22.2579.2579
Published: 2009
Journal Articles

Glial Fibrillary Acidic Protein as a Plasma Biomarker of Brain Injury in Children with Sickle Cell Disease.

William J Savage, MD, Zongming Fu, PhD, Emily Barron-Casella, PhD, Pratima Dulloor, Jacky Jennings, PhD, Elizabeth Dackiw, Kimberly Jones, Lisa M. Williams, MD, Barbara Crain, MD, PhD, Bruce A Barton, PhD, Jennifer Van Eyk, PhD, Michael R. DeBaun, MD, MPH, James F. Casella, MD, Allen Everett, MD
Journal: Blood
Blood (2009) 114 (22): 1512.
https://doi.org/10.1182/blood.V114.22.1512.1512
Published: 2009